SCHEMBL7605575

SCHEMBL7605575

COc1cc2c(cc1Br)CC(C)=NN=C2c1ccccc1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.43
CYP3A4 P08684 2/20 0.43
CYP2C9 P11712 2/20 0.43
CYP2C19 P33261 2/20 0.43
ALDH1A1 P00352 2/20 0.43
MAPT P10636 2/20 0.43
MEN1 O00255 1/20 0.43
CYP2D6 P10635 1/20 0.43
NFKB1 P19838 1/20 0.43
GRIA2 P42262 1/20 0.43
KMT2A Q03164 1/20 0.43
HIF1A Q16665 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
LMNA P02545 2/20 0.43
MAPK10 P53779 4/20 0.41
PDGFRB P09619 1/20 0.41
MAPK1 P28482 1/20 0.39
ABCB1 P08183 1/20 0.36
ABCC1 P33527 1/20 0.36
ABCG2 Q9UNQ0 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7410880 0.91 PDGFRB (0.49) CYP1A2CYP3A4CYP2C9CYP2C19ALDH1A1
SCHEMBL15974264 0.83 CHEK1 (0.51) CYP1A2CYP3A4CYP2C9CYP2C19ALDH1A1
SCHEMBL7606361 0.82 APP (0.43) CYP1A2CYP3A4CYP2C9CYP2C19ALDH1A1
SCHEMBL15985265 0.82 MAPK10 (0.52) CYP1A2CYP3A4CYP2C9CYP2C19ALDH1A1
SCHEMBL7611763 0.81 ALDH1A1 (0.45) CYP1A2CYP3A4CYP2C9CYP2C19ALDH1A1
SCHEMBL7436927 0.78 PDE7A (0.46) CYP1A2CYP3A4CYP2C9CYP2C19ALDH1A1
SCHEMBL15985262 0.78 CYP1A2 (0.41) CYP1A2CYP3A4CYP2C9CYP2C19ALDH1A1
Nerisopam SCHEMBL1004757 0.77 CYP1A2 (0.63) CYP1A2CYP3A4CYP2C9CYP2C19ALDH1A1
SCHEMBL7439770 0.77 MAPT (0.47) CYP1A2CYP3A4CYP2C9CYP2C19ALDH1A1
Nerisopam SCHEMBL8349837 0.77 CYP1A2 (0.63) CYP1A2CYP3A4CYP2C9CYP2C19ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0888313-B1 2,3-BENZODIAZEPINE DERIVATIVES AND THEIR USE AS AMPA-RECEPTOR INHIBITORS SCHERING AG (DE) 2002-04-17 EP disclosed
US-6200970-B1 FOR TREATING A DISEASE ASSOCIATED WITH OVERSTIMULATION OF AN AMPA RECEPTOR, OR HYPERACTIVITY OF AN EXCITATORY AMINO ACID SCHERING AKTIENGESELLSCHAFT (DE) 2001-03-13 US disclosed